JNJ Collaborates with Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
By HospiMedica International staff writers Posted on 23 Mar 2020 |
![Illustration Illustration](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2020-03-23/SDD-1008.jpg)
Illustration
Johnson & Johnson’s (New Brunswick, NJ, USA) Janssen Pharmaceutical Companies (Beerse, Belgium) have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) to support the development of a preventive vaccine candidate for COVID-19. The companies have commenced preclinical testing of multiple vaccine prospects, with the aim of identifying a COVID-19 vaccine candidate for clinical trials by the end of the month.
Janssen’s vaccine program will use the Janssen AdVac and PER.C6 technologies that provide the ability to rapidly upscale production of an optimal vaccine candidate. The company is leveraging its proven vaccine technology that it is also using to develop its investigational Ebola (which also utilizes its MVA-BN technology), Zika, RSV and HIV vaccines. Research and collaboration on preclinical work for Johnson & Johnson’s Zika and HIV vaccine candidates at the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center was foundational to developing these vaccines.
Johnson & Johnson’s efforts to expedite development and production of a vaccine are enhanced by the existing COVID-19 vaccine collaborations between Janssen and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the US Department of Health & Human Services. In addition to Janssen’s efforts to develop a vaccine candidate, the company is working closely with global strategic partners to screen its library of antiviral molecules to accelerate the discovery of potential COVID-19 treatments and provide relief for people around the world. Janssen is optimistic that, in collaboration with multiple global strategic partners, it can initiate a Phase 1 clinical study of a potential vaccine candidate by the end of the year. In parallel to these efforts, Janssen is preparing to upscale production and manufacturing capacities to levels required to meet global public health vaccination needs.
“It is critical to work with the best scientific minds as we look to rapidly identify and develop solutions to the COVID-19 outbreak,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “We are grateful for talented and experienced collaboration partners like Dan Barouch and his team at BIDMC. By mobilizing our collective resources, we believe we can leverage the top science and cutting-edge capabilities to respond to this pandemic.”
“We are currently evaluating a series of potential vaccine candidates for COVID-19. This collaboration with Janssen is aimed at the development of a COVID-19 vaccine that would allow for rapid development, large-scale manufacturing, and global delivery,” said Dan Barouch, M.D., Ph.D., Director of the Center for Virology and Vaccine Research at BIDMC and the Ragon Institute.
Related Links:
Johnson & Johnson
Janssen Pharmaceutical Companies
Beth Israel Deaconess Medical Center (BIDMC)
Janssen’s vaccine program will use the Janssen AdVac and PER.C6 technologies that provide the ability to rapidly upscale production of an optimal vaccine candidate. The company is leveraging its proven vaccine technology that it is also using to develop its investigational Ebola (which also utilizes its MVA-BN technology), Zika, RSV and HIV vaccines. Research and collaboration on preclinical work for Johnson & Johnson’s Zika and HIV vaccine candidates at the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center was foundational to developing these vaccines.
Johnson & Johnson’s efforts to expedite development and production of a vaccine are enhanced by the existing COVID-19 vaccine collaborations between Janssen and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the US Department of Health & Human Services. In addition to Janssen’s efforts to develop a vaccine candidate, the company is working closely with global strategic partners to screen its library of antiviral molecules to accelerate the discovery of potential COVID-19 treatments and provide relief for people around the world. Janssen is optimistic that, in collaboration with multiple global strategic partners, it can initiate a Phase 1 clinical study of a potential vaccine candidate by the end of the year. In parallel to these efforts, Janssen is preparing to upscale production and manufacturing capacities to levels required to meet global public health vaccination needs.
“It is critical to work with the best scientific minds as we look to rapidly identify and develop solutions to the COVID-19 outbreak,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. “We are grateful for talented and experienced collaboration partners like Dan Barouch and his team at BIDMC. By mobilizing our collective resources, we believe we can leverage the top science and cutting-edge capabilities to respond to this pandemic.”
“We are currently evaluating a series of potential vaccine candidates for COVID-19. This collaboration with Janssen is aimed at the development of a COVID-19 vaccine that would allow for rapid development, large-scale manufacturing, and global delivery,” said Dan Barouch, M.D., Ph.D., Director of the Center for Virology and Vaccine Research at BIDMC and the Ragon Institute.
Related Links:
Johnson & Johnson
Janssen Pharmaceutical Companies
Beth Israel Deaconess Medical Center (BIDMC)
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel![Image: AI-powered algorithm could better assess people’s risk of common heart condition (Photo courtesy of 123RF) Image: AI-powered algorithm could better assess people’s risk of common heart condition (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-12-18/SDD-294799622.jpg)
AI-Powered Algorithm to Revolutionize Detection of Atrial Fibrillation
Atrial fibrillation (AFib), a condition characterized by an irregular and often rapid heart rate, is linked to increased risks of stroke and heart failure. This is because the irregular heartbeat in AFib... Read more![Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF) Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-10-12/SDD-294798935.jpg)
AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors
Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves.... Read moreCritical Care
view channel![Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group) Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-03/header.jpg)
Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more![Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF) Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-02/201328584_m_normal_none.jpg)
Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more![Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri) Image: A demonstration of the on-skin wearable bioelectronic device (Photo courtesy of University of Missouri)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-01/240325-Zheng-Yan-Lab-Self-Charging-Wearable-Bioelectronics-P1092444-Enhanced-NR_edit-940x627-1.jpg)
On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
A team of researchers at the University of Missouri (Columbia, MO, USA) has achieved a milestone in developing a state-of-the-art on-skin wearable bioelectronic device. This development comes from a lab... Read more![Image: The Esprit BTK System has received FDA approval for arteries below the knee (Photo courtesy of Abbott) Image: The Esprit BTK System has received FDA approval for arteries below the knee (Photo courtesy of Abbott)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-30/pad-life-btk-scaffold-630x390.jpg)
First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
Peripheral artery disease (PAD) affects millions and presents serious health risks, particularly its severe form, chronic limb-threatening ischemia (CLTI). CLTI develops when arteries are blocked by plaque,... Read moreSurgical Techniques
view channel![Image: The renal ECM-based sponge material facilitates rapid hemostasis and wound healing (Photo courtesy of Professor Dong-Woo Cho, POSTECH) Image: The renal ECM-based sponge material facilitates rapid hemostasis and wound healing (Photo courtesy of Professor Dong-Woo Cho, POSTECH)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-02/postech.jpg)
Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
The kidneys are essential organs that handle critical bodily functions, including waste elimination and blood pressure regulation. Often referred to as the silent organ because they typically do not manifest... Read more![Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science) Image: The hyperspectral imaging system extracts molecular vibrations of different resins and distinguishes between them with high reproducibility (Photo courtesy of Hiroshi Takemura from Tokyo University of Science)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-30/20240426_1672_02.jpg)
Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
Hyperspectral imaging (HSI) is an advanced technique that captures and processes information across a given electromagnetic spectrum. Near-infrared hyperspectral imaging (NIR-HSI) has particularly gained... Read more![Image: The tiny, flexible devices can wrap around individual nerve fibers without damaging them (Photo courtesy of 123RF) Image: The tiny, flexible devices can wrap around individual nerve fibers without damaging them (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-29/205406549_m_normal_none.jpg)
Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
Electric nerve implants serve dual functions: they can either stimulate or block signals in specific nerves. For example, they may alleviate pain by inhibiting pain signals or restore movement in paralyzed... Read more![Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego) Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-26/Dayeh_ScienceTM_April_2024_images_for_release-1.jpg)
Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read morePatient Care
view channel![Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners) Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-05-01/Freestyle_1.jpg)
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more![Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu) Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-09-26/SDD-294798729.jpg)
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more![Image: The Instrument Pod is clinically proven to make the OR and sterile processing more efficient (Photo courtesy of Turbett Surgical) Image: The Instrument Pod is clinically proven to make the OR and sterile processing more efficient (Photo courtesy of Turbett Surgical)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-07-13/SDD-294797885.jpg)
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel![Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai) Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-26/SDD-294797344.jpg)
Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients
Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more![Image: Integration of generative AI into healthcare can increase productivity and enhance patient care (Photo courtesy of Microsoft) Image: Integration of generative AI into healthcare can increase productivity and enhance patient care (Photo courtesy of Microsoft)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-16/SDD-294797200.jpg)
Strategic Collaboration to Develop and Integrate Generative AI into Healthcare
Top industry experts have underscored the immediate requirement for healthcare systems and hospitals to respond to severe cost and margin pressures. Close to half of U.S. hospitals ended 2022 in the red... Read more![Image: iQueue for Operating Rooms maximizes OR access by optimizing block and open time (Photo courtesy of Freepik) Image: iQueue for Operating Rooms maximizes OR access by optimizing block and open time (Photo courtesy of Freepik)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-10/SDD-294797132.jpg)
AI-Enabled Operating Rooms Solution Helps Hospitals Maximize Utilization and Unlock Capacity
For healthcare organizations, optimizing operating room (OR) utilization during prime time hours is a complex challenge. Surgeons and clinics face difficulties in finding available slots for booking cases,... Read more![Image: AI model spots those at highest risk for up to three years before diagnosis (Photo courtesy of Freepik) Image: AI model spots those at highest risk for up to three years before diagnosis (Photo courtesy of Freepik)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2023-05-10/SDD-294797117.jpg)
AI Predicts Pancreatic Cancer Three Years before Diagnosis from Patients’ Medical Records
Screening for common cancers like breast, cervix, and prostate cancer relies on relatively simple and highly effective techniques, such as mammograms, Pap smears, and blood tests. These methods have revolutionized... Read morePoint of Care
view channel![Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics) Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-05/Quantra_Instrument_QStat_Dials_2022.jpg)
Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing
Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more![Image: The Xpert HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification (Photo courtesy of Cepheid) Image: The Xpert HIV-1 Qual XC has been awarded World Health Organization (WHO) prequalification (Photo courtesy of Cepheid)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-04/Cepheid-Xpert-HIV-1-Qual-XC-Cartridge-Front.jpg)
Point of Care HIV Test Enables Early Infection Diagnosis for Infants
Early diagnosis and initiation of treatment are crucial for the survival of infants infected with HIV (human immunodeficiency virus). Without treatment, approximately 50% of infants who acquire HIV during... Read more![Image: The i-STAT TBI cartridge has received FDA clearance to be used with whole blood (Photo courtesy of Abbott) Image: The i-STAT TBI cartridge has received FDA clearance to be used with whole blood (Photo courtesy of Abbott)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-02/i-stat-tbi-imagea-375.jpg)
Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside
In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked.... Read more![Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical) Image: The new generation StatStrip Glucose Hospital Meter has obtained FDA 510k clearance (Photo courtesy of Nova Biomedical)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-02/New_meter_angled.jpg)
New Generation Glucose Hospital Meter System Ensures Accurate, Interference-Free and Safe Use
A new generation glucose hospital meter system now comes with several features that make hospital glucose testing easier and more secure while continuing to offer accuracy, freedom from interference, and... Read moreBusiness
view channel![Image: Shockwave offers the first and only commercially available IVL platform for CAD and PAD (Photo courtesy of Shockwave Medical) Image: Shockwave offers the first and only commercially available IVL platform for CAD and PAD (Photo courtesy of Shockwave Medical)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-04-08/shockwave-device-c2.jpg)
Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
Johnson & Johnson (New Brunswick, N.J., USA) and Shockwave Medical (Santa Clara, CA, USA) have entered into a definitive agreement under which Johnson & Johnson will acquire all of Shockwave’s... Read more![Image: Mindray has planned a USD 927 million deal to control APT Medical (Photo courtesy of Mindray) Image: Mindray has planned a USD 927 million deal to control APT Medical (Photo courtesy of Mindray)](https://globetechcdn.com/mobile_hospimedica/images/stories/articles/article_images/2024-02-05/acquire-apt-medical-kv-pc.jpg)